ID Migraine screener found to be highly reliable in detecting migraine in undiagnosed patients

August 13, 2003

NEW YORK, August 13, 2003 -- A simple three-question test, called ID Migraine, can identify patients with migraine with about the same accuracy as widely used screening tests for other illnesses. It was developed by a team of migraine researchers and validated in a national study. The results appear in the current issue of Neurology, the journal of the American Academy of Neurology. The authors report that answering "yes" to two out of three simple questions effectively identifies migraine sufferers. The questions were:According to the lead author, Richard B. Lipton, M.D. Professor and Vice Chair of Neurology at the Albert Einstein College of Medicine, ID Migraine should be used in a primary care setting, where many patients with migraine may go undiagnosed. About 28 million Americans are estimated to suffer from migraine, but less than half have ever been diagnosed by a doctor, and may be frustrated because they can't find effective treatment.

"Despite the high prevalence of migraine and its associated pain and disability, diagnostic rates for migraine remain low," Dr. Lipton said. "ID Migraine is very easy to use for both patients and doctors and we hope it will prompt patients to talk to their primary care doctor to get diagnosed and to receive treatments that will relieve their pain and improve their ability to function."

The authors tested the validity and reliability of ID Migraine at 27 primary care sites and 12 headache specialty practice sites in the U.S. A nine-question survey was completed by 443 patients making routine primary care physician visits for any reason. Patients in the study either had headaches that interfered with their ability to work, study, or their enjoyment of life; or said they wanted to talk to their physicians about their headaches. All the patients were then referred to one of 12 headache specialty centers, where specialists diagnosed them without knowing how they had answered the questionnaire. The patients' medical diagnoses were compared to the answers given to the questionnaires. An analysis identified the three questions that best predicted a migraine diagnosis; of patients who answered "yes" to two of the three questions, 93 percent were diagnosed by the headache experts as suffering from migraines.

"Because patients with migraine often present in the primary care setting, the hope is that ID Migraine will help primary care doctors identify migraine quickly and easily," Dr. Lipton said. "Given the availability of effective treatment, use of the screening tool might represent an important step toward reducing the burden of this illness."

"Headaches sometimes have serious causes not identified by the screener. Whether a patient has migraine or headaches due to other conditions, the ID migraine screener can help facilitate patient physician communication and the exchange of important information," Dr. Lipton added.

Co-authors of the paper were: K. Kolodner, D. Dodick, R. Sadovsky, J. Endicott, J. Hettiarachchi and W. Harrison. The study was supported by funding from Pfizer Inc.

Migraine is more common than diabetes (16 million) and asthma (10.6 million). It is more prevalent in women: almost one in five women and one in 15 men suffer from migraine. The prevalence of migraine peaks at approximately 40 years of age, making it most common during the peak productive years of 25 to 55.

Fifty percent of individuals reported in one study that during their migraine attacks, they experience severe functional impairment and may require complete bed rest. The impairment and impact on health-related quality of life of migraine is substantial, equivalent to or greater than other chronic medical illnesses such as angina, diabetes, and hypertension. The economic impact of migraine is also substantial, with the annual cost to employers, in terms of reduced productivity and days missed from work, estimated at more than $13 billion, and annual medical costs that exceed $2 billion. The World Health Organization (WHO) ranks migraine among the world's top 20 most disabling medical illnesses.

M Booth & Associates

Related Migraine Articles from Brightsurf:

Disparities in migraine by sexual orientation
Survey data were used to examine the association between sexual orientation (exclusively heterosexual, mostly heterosexual, lesbian, gay or bisexual) and migraine.

Can you paint your migraine?
'Can you draw me a picture of your headache?' may sound like an unusual question - but drawings of headache pain provide plastic surgeons with valuable information on which patients are more or less likely to benefit from surgery to alleviate migraine headaches.

Acupuncture can reduce migraine headaches
Acupuncture can reduce migraine headaches compared to both sham (placebo) acupuncture and usual care, finds a new trial from China published by The BMJ today.

Migraine rats, medical facts
Migraine mechanisms are still far from being fully understood. Escalating data from animal models are 'fact-checking' the neurophysiological and behavioral correlates of the migraine experience in humans, and how they may be affected by current anti-migraine drugs or might translate into new therapies.

Connecting the dots in the migraine brain
This dMRI study pointed to the structural strengthening of connections involving subcortical regions associated with pain processing and weakening in connections involving cortical regions associated with hyperexcitability may coexist in migraine.

Predictors of chronic migraine
A review and meta-analysis found predictors of chronic migraine. Depression, high frequency attacks, medication overuse and allodynia increased the chances for new onset chronic migraine, while annual income -- US$ 50,000 showed a protective effect.

On nitroglycerin, cardiovascular homeostasis and...bam, migraine!
Researchers in Leiden, The Netherlands, found an exaggerated cardiovascular response to nitroglycerin infusion in migraine patients, suggesting an elevated systemic sensitivity to this compound in this population.

All roads lead to migraine
Dr. Samaira Younis, from the Danish Headache Center in Copenhagen, Denmark, shares her research results, which suggests there are no differences between migraine attacks clinical characteristics following administration of 2 different compounds in patients, CGRP and sildenafil, meaning they share common cellular signaling pathways.

Running away from exercise: The curious case of migraine
In spite of the widespread recommendation for regular physical activity as a strategy to manage migraine, for some patients, exercise can instead trigger migraine attacks.

Migraine prevention in children and adolescents
Two medicines already used to prevent migraine in adults also showed efficacy in adolescents with migraine.

Read More: Migraine News and Migraine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to